Dear Senator Tester, Senator Daines, and Representative Rosendale,
While you and your colleagues continue to search for a solution to high prescription drug costs, we urge you to protect patients access to medicine and innovative new treatments, and focus on directly addressing out-of-pocket costs. The recently introduced drug pricing proposal, H.R. 3 (Speaker Pelosi’s legislation), limits innovation and decreases access to treatment options. This is bad policy. It is critical that Congress takes a more patient-centric approach to lowering the cost of prescriptions than what is included in this legislation.
Full letter:
HR3-Montana-Sign-on-Letter-to-Delegation